Stocks
Gossamer Bio (GOSS) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -34.8% | -334.7% | -330.4% | |||||
| Changes by years, y/y, % | -300pp | +860.7% | |||||||
Gossamer Bio. EBITDA margin, %
Gossamer Bio. EBITDA margin, changes, pp
Gossamer Bio (GOSS) EBITDA margin US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EBITDA margin, % | ? | -337.2% | -339.3% | -307.4% | -342.0% | -332.0% | -330.4% | |
| Changes by years, y/y, % | -367pp | -46pp | +5pp | |||||
| Changes by quarters, q/q, % | -41pp | -2pp | +32pp | -35pp | +10pp | |||
